| 1461P Impact of first-line (1L) therapy on outcomes of adult patients (pts) with metastatic MiT family translocation renal cell carcinomas (TRCC) treated in the contemporary … J Thouvenin, O Alhalabi, M Carlo, LC Ajuria, Z Bakouny, NM Chanza, ... Annals of Oncology 33, S1213-S1214, 2022 | | 2022 |
| 1526P The experience of onco-palliative care multidisciplinary meetings in Hotel Dieu de France University Hospital, an ESMO designated center of integrated oncology and … A Houchan, TS Assi, Z Bakouny, E El Rassy, A Tohme, MC Mouhawej, ... Annals of Oncology 29 (suppl_8), mdy295. 015, 2018 | | 2018 |
| 252P Real-world progression-free survival (rwPFS) and time to next line of therapy (TTNT) as intermediate endpoints for survival in metastatic breast cancer: A real-world … C Labaki, Z Bakouny, T Sanglier, A Schmidt, J Shim, DA Braun, F Bouquet, ... Annals of Oncology 33, S652, 2022 | 1 | 2022 |
| 502P Association of immunotherapy and immunosuppression with severe COVID-19 disease in patients with cancer Z Bakouny, P Grover, C Labaki, J Awosika, S Gulati, CY Hsu, MA Bilen, ... Annals of Oncology 33, S772-S773, 2022 | | 2022 |
| 63P A network meta-analysis of the frontline immune-checkpoint inhibitor-based regimens in advanced non-small cell lung cancer JG Kattan, EE Rassy, Z Bakouny, T Assi, N Pavlidis Annals of Oncology 29 (suppl_10), mdy486. 015, 2018 | | 2018 |
| 683P Impact of renin-angiotensin system inhibitors (RASi) on outcomes in patients with metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICI) PV Nuzzo, E Adib, N Weise, C Curran, T Stewart, D Freeman, AH Nassar, ... Annals of Oncology 32, S702-S703, 2021 | | 2021 |
| 9p21 loss defines the evolutionary patterns of aggressive renal cell carcinomas F Carbone, JK Huang, L Perelli, ED Poggetto, T Gutschner, H Tomihara, ... bioRxiv, 2020.11. 03.367433, 2020 | 2 | 2020 |
| A comprehensive review of the role of immune checkpoint inhibitors in brain metastasis of renal cell carcinoma origin J Kattan, E El Rassy, T Assi, Z Bakouny, N Pavlidis Critical reviews in oncology/hematology 130, 60-69, 2018 | 22 | 2018 |
| A functional evaluation of pincer femoroacetabular impingement in asymptomatic adults Z Bakouny, A Assi, A Massaad, F Yared, M Karam, N Khalil, V Lafage, ... | | |
| A network meta-analysis of the PD (L)-1 inhibitors in the salvage treatment of urothelial bladder cancer EE Rassy, Z Bakouny, F Aoun, FG Haddad, G Sleilaty, T Assi, J Kattan Immunotherapy 10 (8), 657-663, 2018 | 12 | 2018 |
| A new approach in the clinical decision-making for cerebral palsy using three-dimensional subject-specific musculoskeletal reconstructions. A Massaad, A Assi, Z Bakouny, W Skalli, I Ghanem Lebanese Medical Journal 64 (3), 152-159, 2016 | 2 | 2016 |
| A panel-based mutational signature of homologous recombination deficiency associates with response to PARP inhibition in metastatic castration-resistant prostate cancer D Boiarsky, A Tewari, D Gulhan, Z Bakouny, G Ananda, H Savignano, ... MOLECULAR CANCER THERAPEUTICS 22 (12), 2023 | | 2023 |
| A podoscopic and descriptive study of foot deformities in patients with Down syndrome E Mansour, JJ Yaacoub, Z Bakouny, A Assi, I Ghanem Orthopaedics & Traumatology: Surgery & Research 103 (1), 123-127, 2017 | 30 | 2017 |
| A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance M Abidi, DM Aboulafia, MK Accordino, JD Acoba, MS Ahluwalia, ... Cancer Cell 38 (6), 761-766, 2020 | 18 | 2020 |
| Abstract A029: Epigenomic profiling nominates master transcription factors (TFs) driving sarcomatoid differentiation of renal cell carcinoma (RCC) K Semaan, TE Zarif, M Eid, V Shah, B Fortunato, RM Saliby, AH Nassar, ... Cancer Research 83 (16_Supplement), A029-A029, 2023 | | 2023 |
| Abstract B009: A panel-based mutational signature of homologous recombination deficiency associates with response to PARP inhibition in metastatic castration-resistant prostate … D Boiarsky, A Tewari, D Gulhan, Z Bakouny, G Ananda, H Savignano, ... Molecular Cancer Therapeutics 22 (12_Supplement), B009-B009, 2023 | | 2023 |
| Abstract B019: Clinical and molecular characterization of chromophobe renal cell carcinoma: A focus on immunotherapy based regimens and the tumor immune microenvironment M Alchoueiry, C Labaki, L Zhang, Y Hou, K Bi, C Hobeika, JC Wells, ... Cancer Research 83 (16_Supplement), B019-B019, 2023 | | 2023 |
| Abstract S06-02: Disruption to care of patients with thoracic malignancies: A COVID-19 and cancer outcomes study S Bhalla, Z Bakouny, AL Schmidt, JA Steinharter, DA Tremblay, MM Awad, ... Clinical Cancer Research 27 (6_Supplement), S06-02-S06-02, 2021 | | 2021 |
| ACE2 abrogates tumor resistance to VEGFR inhibitors suggesting angiotensin-(1-7) as a therapy for clear cell renal cell carcinoma P Khanna, HJ Soh, CH Chen, R Saxena, S Amin, M Naughton, PN Joslin, ... Science Translational Medicine 13 (577), eabc0170, 2021 | 37 | 2021 |
| Acetabulum and lower limb morphology in spastic diplegia with different gait patterns A Massaad, A Assi, N Khalil, F Yared, Z Bakouny, W Skalli, I Ghanem Gait & Posture 49, 82, 2016 | | 2016 |
Toni ChoueiriDana-Farber Cancer Institute在 dfci.harvard.edu 的电子邮件经过验证
